Faouzi I Maalouf1, William O Cooper2,3,4, Shannon M Stratton3, Judith A Dudley3, Jean Ko5,6, Anamika Banerji7, Stephen W Patrick8,3,4. 1. Department of Pediatrics and Adolescent Medicine, American University of Beirut, Beirut, Lebanon. 2. Departments of Pediatrics and. 3. Health Policy, Vanderbilt University, Nashville, Tennessee. 4. Vanderbilt Center for Child Health Policy, Nashville, Tennessee. 5. Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, Georgia. 6. United States Public Health Service Commissioned Corps, Rockville, Maryland; and. 7. Division of Neonatology, Loma Linda University, Loma Linda, California. 8. Departments of Pediatrics and stephen.patrick@vanderbilt.edu.
Abstract
OBJECTIVES: Neonatal abstinence syndrome (NAS) is a postnatal withdrawal syndrome experienced by some infants with opioid exposure. Hospital administrative data are commonly used for research and surveillance but have not been validated for NAS. Our objectives for this study were to validate the diagnostic codes for NAS and to develop an algorithm to optimize identification. METHODS: Tennessee Medicaid claims from 2009 to 2011 (primary sample) and 2016 (secondary sample; post-International Classification of Diseases, 10th Revision, Clinical Modification [ICD-10-CM]) were obtained. Cases of NAS were identified by using International Classification of Diseases, Ninth Revision, Clinical Modification code (2009-2011) 779.5 and ICD-10-CM code (2016) P96.1. Medical record review cases were then conducted by 2 physicians using a standardized algorithm, and positive predictive value (PPV) was calculated. Algorithms were developed for optimizing the identification of NAS in administrative data. RESULTS: In our primary sample of 112 029 mother-infant dyads, 950 potential NAS cases were identified from Medicaid claims data and reviewed. Among reviewed records, 863 were confirmed as having NAS (including 628 [66.1%] cases identified as NAS requiring pharmacotherapy, 224 [23.5%] as NAS not requiring pharmacotherapy, and 11 [1.2%] as iatrogenic NAS), and 87 (9.2%) did not meet clinical criteria for NAS. The PPV of the International Classification of Diseases, Ninth Revision, Clinical Modification code for NAS in clinically confirmed NAS was 91% (95% confidence interval: 88.8%-92.5%). Similarly, the PPV for the ICD-10-CM code in the secondary sample was 98.2% (95% confidence interval: 95.4%-99.2%). Algorithms using elements from the Medicaid claims and from length of stay improved PPV. CONCLUSIONS: In a large population-based cohort of Medicaid participants, hospital administrative data had a high PPV in identifying cases of clinically diagnosed NAS.
OBJECTIVES:Neonatal abstinence syndrome (NAS) is a postnatal withdrawal syndrome experienced by some infants with opioid exposure. Hospital administrative data are commonly used for research and surveillance but have not been validated for NAS. Our objectives for this study were to validate the diagnostic codes for NAS and to develop an algorithm to optimize identification. METHODS: Tennessee Medicaid claims from 2009 to 2011 (primary sample) and 2016 (secondary sample; post-International Classification of Diseases, 10th Revision, Clinical Modification [ICD-10-CM]) were obtained. Cases of NAS were identified by using International Classification of Diseases, Ninth Revision, Clinical Modification code (2009-2011) 779.5 and ICD-10-CM code (2016) P96.1. Medical record review cases were then conducted by 2 physicians using a standardized algorithm, and positive predictive value (PPV) was calculated. Algorithms were developed for optimizing the identification of NAS in administrative data. RESULTS: In our primary sample of 112 029 mother-infant dyads, 950 potential NAS cases were identified from Medicaid claims data and reviewed. Among reviewed records, 863 were confirmed as having NAS (including 628 [66.1%] cases identified as NAS requiring pharmacotherapy, 224 [23.5%] as NAS not requiring pharmacotherapy, and 11 [1.2%] as iatrogenic NAS), and 87 (9.2%) did not meet clinical criteria for NAS. The PPV of the International Classification of Diseases, Ninth Revision, Clinical Modification code for NAS in clinically confirmed NAS was 91% (95% confidence interval: 88.8%-92.5%). Similarly, the PPV for the ICD-10-CM code in the secondary sample was 98.2% (95% confidence interval: 95.4%-99.2%). Algorithms using elements from the Medicaid claims and from length of stay improved PPV. CONCLUSIONS: In a large population-based cohort of Medicaid participants, hospital administrative data had a high PPV in identifying cases of clinically diagnosed NAS.
Authors: Stephen W Patrick; Robert E Schumacher; Brian D Benneyworth; Elizabeth E Krans; Jennifer M McAllister; Matthew M Davis Journal: JAMA Date: 2012-04-30 Impact factor: 56.272
Authors: Susan E Andrade; Pamela E Scott; Robert L Davis; De-Kun Li; Darios Getahun; T Craig Cheetham; Marsha A Raebel; Sengwee Toh; Sascha Dublin; Pamala A Pawloski; Tarek A Hammad; Sarah J Beaton; David H Smith; Inna Dashevsky; Katherine Haffenreffer; William O Cooper Journal: Pharmacoepidemiol Drug Saf Date: 2012-07-03 Impact factor: 2.890
Authors: Charlie Tan; Mark Hansen; Gideon Cohen; Karl Boyle; Nick Daneman; Neill K J Adhikari Journal: Int J Cardiol Date: 2016-09-17 Impact factor: 4.164
Authors: William O Cooper; Sonia Hernandez-Diaz; Patricia Gideon; Shannon M Dyer; Kathleen Hall; Judith Dudley; Marisa Cevasco; Amanda B Thompson; Wayne A Ray Journal: Pharmacoepidemiol Drug Saf Date: 2008-05 Impact factor: 2.890
Authors: William V Bobo; William O Cooper; Richard A Epstein; Patrick G Arbogast; Jackie Mounsey; Wayne A Ray Journal: BMC Med Res Methodol Date: 2011-11-23 Impact factor: 4.615
Authors: Rishi J Desai; Krista F Huybrechts; Sonia Hernandez-Diaz; Helen Mogun; Elisabetta Patorno; Karol Kaltenbach; Leslie S Kerzner; Brian T Bateman Journal: BMJ Date: 2015-05-14
Authors: Krista F Huybrechts; Brian T Bateman; Rishi J Desai; Sonia Hernandez-Diaz; Kathryn Rough; Helen Mogun; Leslie S Kerzner; Jonathan M Davis; Megan Stover; Devan Bartels; Jennifer Cottral; Elisabetta Patorno Journal: BMJ Date: 2017-08-02
Authors: Ashley A Leech; William O Cooper; Elizabeth McNeer; Theresa A Scott; Stephen W Patrick Journal: Health Aff (Millwood) Date: 2020-05 Impact factor: 6.301
Authors: Lauren A Sanlorenzo; William O Cooper; Judith A Dudley; Shannon Stratton; Faouzi I Maalouf; Stephen W Patrick Journal: Hosp Pediatr Date: 2019-07-01
Authors: Kathleen M Doherty; Theresa A Scott; Anna Morad; Travis Crook; Elizabeth McNeer; Kim S Lovell; James C Gay; Stephen W Patrick Journal: Pediatrics Date: 2020-12-02 Impact factor: 7.124
Authors: Emery R Eaves; Jarrett Barber; Ryann Whealy; Sara A Clancey; Rita Wright; Jill Hager Cocking; Joseph Spadafino; Crystal M Hepp Journal: PLoS One Date: 2021-06-03 Impact factor: 3.752
Authors: Benjamin A Howell; Erica A Abel; Dongchan Park; Sara N Edmond; Leah J Leisch; William C Becker Journal: J Gen Intern Med Date: 2020-11-11 Impact factor: 5.128
Authors: Stephen W Patrick; James C Slaughter; Frank E Harrell; Peter R Martin; Katherine Hartmann; Judith Dudley; Shannon Stratton; William O Cooper Journal: J Pediatr Date: 2020-10-17 Impact factor: 4.406
Authors: Laura E Henkhaus; Melinda B Buntin; Sarah Clark Henderson; Pikki Lai; Stephen W Patrick Journal: Subst Abus Date: 2021-07-16 Impact factor: 3.716